Oncology Institute, Inc. (TOI) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$24.59M | +7.4% |
| 2024 | -$26.54M | +26.9% |
| 2023 | -$36.31M | +41.2% |
| 2022 | -$61.76M | -89.0% |
| 2021 | -$32.68M | -6533.1% |
| 2020 | $508.0K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$24.59M | +7.4% |
| 2024 | -$26.54M | +26.9% |
| 2023 | -$36.31M | +41.2% |
| 2022 | -$61.76M | -89.0% |
| 2021 | -$32.68M | -6533.1% |
| 2020 | $508.0K | — |